BismuthH., SamuelD., CastaingD., WilliamsR., PereiraS.P.. Liver transplantation in Europe for patients with acute liver failure.Semin Liver Dis1996; 16: 415–25.
2.
SenS., WilliamsR., JalanR.. The pathophysiological basis of acute on chronic liver failure.Liver2002; (suppl 2): S5–13.
3.
HughesR.D.. Review of methods to remove protein-bound substances in liver failure.Int J Artif Organs2002; 25: 911–7.
4.
O'GradyJ.G., GimsonA.E., O'BrienC.J.. Controlled trials of charcoal haemoperfusion and prognostic factors in fulminant hepatic failure.Gastroenterology1988; 94: 1186–92.
5.
HughesR.D., PucknellA., RoutleyD., LangleyP.G., WendonJ.A., WilliamsR.. Evaluation of the BioLogic-DT sorbent suspension dialyser in patients with fulminant hepatic failure.Int J Artif Organs1994; 17: 657–62.
6.
KramerL., GendoA., MadlC.. A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy.Int J Artif Organs2001; 24: 434–42.
7.
LarsenF.S., HansenB.A., JorgensenL.G., SecherN.H., BondensenS., LinkisP., HjorturupA., KirkegaardP., AgerlinN., KondrupJ.. Cerebral blood flow velocity during high volume plasmapheresis in fulminant hepatic failure.Int J Artif Organs1994; 17: 353–61.
8.
StangeJ., MitznerS., RamlowW., GlescheT., HicksteinH., ScmidtR.. A new procedure for the removal of protein bound drugs and toxins.ASAIO J1993; 39: M621–5.
9.
StangeJ., MitznerS.R., RislerT., ErleyC.M., LauchartW., GoehlH.. Molecular adsorbent recycling system (MARS): clinical results of a new membrane based blood purification system for bio-artificial liver support.Artif Organs1999; 23: 319–30.
10.
StangeJ., HassaneinT.I., MehtaR., MitznerS.R., BartlettR.H.. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: A summary of preclinical investigations, prospective, randomised, controlled clinical trials, and clinical experience from 19 centres.Artif Organs2002; 26: 103–10.
11.
RittlerP., KetscherC., InthornD., JauchK.W., HartlW.H.. Use of the molecular adsorbent recycling system in the treatment of postoperative hepatic failure and septic multiple organ dysfunction- preliminary results.Liver Int2004; 24: 136–41.
12.
MitznerS., StangeJ., KlammtS.. Improvement of the hepato-renal syndrome with extracorporeal albumin dialysis MARS: results of a prospective controlled clinical trial.Liver Transpl2000; 6: 277–86.
13.
HeemanU., TreichelU., LoockJ.. Albumin dialysis in cirrhosis with superimposed acute liver injury; a prospective, controlled study.Hepatology2002; 36: 949–58.
14.
ScmidtL.E., SorensenV.R., SvendsenL.B., HansenB.A., LarsenF.S.. Haemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure.Liver Transpl2001; 7: 1034–9.
15.
ScmidtL.E., WangL.P., HansenB.A., LarsenF.S.. Systemic haemodynamic effects of treatment with with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial.Liver Transpl2003; 9: 290–7.
16.
FalkenhagenD., StroblW., VogtG., SchreflA., LinsbergerI., GernerF.J.. Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.Artif Organs1999; 23: 81–6.
17.
RifaiK., ErnstT., KretshcmerU., BahrM.J., SchneiderA., HaferC., HallerH., MannsM.P., FliserD.. Prometheus® - a new extracorporeal system for the treatment of liver failure.J Hepatol2003; 39: 984–90.
18.
SenP.K., BhaleraoR.A., ParulkarG.P., SamsiA.B., ShahB.K., KinareS.G.. Use of isolated perfused cadaveric liver in the management of hepatic failure.Surgery1996; 59: 774–81.
19.
EisemanB., LiemD.S., RafucciF.. Heterologous liver perfusion in the treatment of hepatic failure.Ann Surg1965; 162: 329–45.
20.
AbounaG.M., SerrouB., BoehmigH.G., AmemiyaH.. Long term hepatic support by intermittent multispecies liver perfusions.Lancet1970; 2: 391.
21.
WattsJ.M.. The treatment of acute hepatic failure by porcine liver perfusion.Med J Aust1969; 1: 324.
22.
PascherA., SauerI.M., NeuhausP.. Analysis of allogeneic versus xenogeneic auxiliary organ perfusion in liver failure reveals superior efficacy of human livers.Int J Artif Organs2002; 25: 1006–12.
23.
EllisA.J., HughesR.D., WendonJ.A., DunneJ., LangleyP.G., KellyJ.H., GislasonG.T., SussmanN.L., WilliamsR.. Pilotcontolled trial of the extracorporeal liver assist device in acute liver failure.Hepatology1996; 24: 1446–51.
24.
DemetriouA., BrownR.S., BusuttilR.W., FairJ., McGuireB.M., RosenthalP.. Prospective, randomised, multicentre, controlled trial of a bioartificial liver in treating acute liver failure.Ann Surg2004; 239: 660–70.
25.
Van de KerkhoveM.P., Di FlorioE., ScuderiV., ManciniA., BelliA.. Phase 1 clinical trial with the AMC- bioartificial liver.Int J Artif Organs2002; 25: 950–9.
26.
SauerI.M., NeuhausP., GerlachJ.C.. Concept for modular extracorporeal liver support for the treatment of acute hepatic failure.Metab Brain Dis2002; 17: 477–84.
27.
SauerI.M., ZeilingerK., ObermayerN., PlessG., GrunwaldA., PascherA.. Primary human liver cells as source for modular extracorporeal liver support - a preliminary report.Int J Artif Organs2002; 25: 1001–5.
28.
BaccaraniU., DoniniA., SannaA., RisalitiA., CarianiA., NardoB.. First report of cryopreserved human hepatocytes based bioartificial liver successfully used as abridge to liver transplantation.Am J Transplant2003; 4: 286–9.
29.
KjaergardL.L., LiuJ., NielsenB., GluudC.. Artificial and bioartificial support systems for acute and acute on chronic liver failure.JAMA2003; 289: 217–22.
